130 related articles for article (PubMed ID: 38657907)
1. Intestinal expression profiles and hepatic expression of LEAP2, ghrelin and their common receptor, GHSR, in humans.
Englund A; Gilliam-Vigh H; Suppli MP; Gasbjerg LS; Vilsbøll T; Knop FK
Peptides; 2024 Jul; 177():171227. PubMed ID: 38657907
[TBL] [Abstract][Full Text] [Related]
2. GHSR controls food deprivation-induced activation of CRF neurons of the hypothalamic paraventricular nucleus in a LEAP2-dependent manner.
Fernandez G; Cabral A; De Francesco PN; Uriarte M; Reynaldo M; Castrogiovanni D; Zubiría G; Giovambattista A; Cantel S; Denoyelle S; Fehrentz JA; Tolle V; Schiöth HB; Perello M
Cell Mol Life Sci; 2022 May; 79(5):277. PubMed ID: 35504998
[TBL] [Abstract][Full Text] [Related]
3. Liver-expressed antimicrobial peptide 2 functions independently of growth hormone secretagogue receptor in calorie-restricted mice.
Islam MN; Zhang W; Sakai K; Nakazato Y; Tanida R; Sakoda H; Takei T; Takao T; Nakazato M
Peptides; 2022 May; 151():170763. PubMed ID: 35151767
[TBL] [Abstract][Full Text] [Related]
4. LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue.
Shankar K; Metzger NP; Singh O; Mani BK; Osborne-Lawrence S; Varshney S; Gupta D; Ogden SB; Takemi S; Richard CP; Nandy K; Liu C; Zigman JM
Mol Metab; 2021 Nov; 53():101327. PubMed ID: 34428557
[TBL] [Abstract][Full Text] [Related]
5. Liver-Expressed Antimicrobial Peptide 2 antagonizes the insulinostatic effect of ghrelin in rat isolated pancreatic islets.
Bayle M; Péraldi-Roux S; Gautheron G; Cros G; Oiry C; Neasta J
Fundam Clin Pharmacol; 2022 Apr; 36(2):375-377. PubMed ID: 34449915
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and analysis of the ghrelin/GHSR system in Xenopus tropicalis.
Wada R; Takemi S; Matsumoto M; Iijima M; Sakai T; Sakata I
Gen Comp Endocrinol; 2023 Jan; 331():114167. PubMed ID: 36402245
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel fluorescent ligand of growth hormone secretagogue receptor based on the N-Terminal Leap2 region.
Barrile F; M'Kadmi C; De Francesco PN; Cabral A; García Romero G; Mustafá ER; Cantel S; Damian M; Mary S; Denoyelle S; Banères JL; Marie J; Raingo J; Fehrentz JA; Perelló M
Mol Cell Endocrinol; 2019 Dec; 498():110573. PubMed ID: 31499133
[TBL] [Abstract][Full Text] [Related]
8. LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor.
Ge X; Yang H; Bednarek MA; Galon-Tilleman H; Chen P; Chen M; Lichtman JS; Wang Y; Dalmas O; Yin Y; Tian H; Jermutus L; Grimsby J; Rondinone CM; Konkar A; Kaplan DD
Cell Metab; 2018 Feb; 27(2):461-469.e6. PubMed ID: 29233536
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone secretagogue receptor signalling affects high-fat intake independently of plasma levels of ghrelin and LEAP2, in a 4-day binge eating model.
Cornejo MP; Castrogiovanni D; Schiöth HB; Reynaldo M; Marie J; Fehrentz JA; Perello M
J Neuroendocrinol; 2019 Oct; 31(10):e12785. PubMed ID: 31469195
[TBL] [Abstract][Full Text] [Related]
10. N-Terminal Liver-Expressed Antimicrobial Peptide 2 (LEAP2) Region Exhibits Inverse Agonist Activity toward the Ghrelin Receptor.
M'Kadmi C; Cabral A; Barrile F; Giribaldi J; Cantel S; Damian M; Mary S; Denoyelle S; Dutertre S; Péraldi-Roux S; Neasta J; Oiry C; Banères JL; Marie J; Perello M; Fehrentz JA
J Med Chem; 2019 Jan; 62(2):965-973. PubMed ID: 30543423
[TBL] [Abstract][Full Text] [Related]
11. A Novel Truncated Liver Enriched Antimicrobial Peptide-2 Palmitoylated at its N-Terminal Antagonizes Effects of Ghrelin.
Holá L; Železná B; Karnošová A; Kuneš J; Fehrentz JA; Denoyelle S; Cantel S; Blechová M; Sýkora D; Myšková A; Maletínská L
J Pharmacol Exp Ther; 2022 Nov; 383(2):129-136. PubMed ID: 36198495
[TBL] [Abstract][Full Text] [Related]
12. High Coexpression of the Ghrelin and LEAP2 Receptor GHSR With Pancreatic Polypeptide in Mouse and Human Islets.
Gupta D; Dowsett GKC; Mani BK; Shankar K; Osborne-Lawrence S; Metzger NP; Lam BYH; Yeo GSH; Zigman JM
Endocrinology; 2021 Oct; 162(10):. PubMed ID: 34289060
[TBL] [Abstract][Full Text] [Related]
13. LEAP2 reduces postprandial glucose excursions and
Hagemann CA; Jensen MS; Holm S; Gasbjerg LS; Byberg S; Skov-Jeppesen K; Hartmann B; Holst JJ; Dela F; Vilsbøll T; Christensen MB; Holst B; Knop FK
Cell Rep Med; 2022 Apr; 3(4):100582. PubMed ID: 35492241
[TBL] [Abstract][Full Text] [Related]
14. Identification and Metabolic Profiling of a Novel Human Gut-derived LEAP2 Fragment.
Hagemann CA; Zhang C; Hansen HH; Jorsal T; Rigbolt KTG; Madsen MR; Bergmann NC; Heimbürger SMN; Falkenhahn M; Theis S; Breitschopf K; Holm S; Hedegaard MA; Christensen MB; Vilsbøll T; Holst B; Vrang N; Jelsing J; Knop FK
J Clin Endocrinol Metab; 2021 Jan; 106(2):e966-e981. PubMed ID: 33135737
[TBL] [Abstract][Full Text] [Related]
15. Beta-Hydroxybutyrate Suppresses Hepatic Production of the Ghrelin Receptor Antagonist LEAP2.
Holm S; Husted AS; Skov LJ; Morville TH; Hagemann CA; Jorsal T; Dall M; Jakobsen A; Klein AB; Treebak JT; Knop FK; Schwartz TW; Clemmensen C; Holst B
Endocrinology; 2022 Jun; 163(6):. PubMed ID: 35352108
[TBL] [Abstract][Full Text] [Related]
16. Involvement of POMC neurons in LEAP2 regulation of food intake and body weight.
Chu G; Peng H; Yu N; Zhang Y; Lin X; Lu Y
Front Endocrinol (Lausanne); 2022; 13():932761. PubMed ID: 36387867
[TBL] [Abstract][Full Text] [Related]
17. Identifying the binding mechanism of LEAP2 to receptor GHSR1a.
Wang JH; Li HZ; Shao XX; Nie WH; Liu YL; Xu ZG; Guo ZY
FEBS J; 2019 Apr; 286(7):1332-1345. PubMed ID: 30666806
[TBL] [Abstract][Full Text] [Related]
18. The dietary regulation of LEAP2 depends on meal composition in mice.
Gradel AKJ; Holm SK; Byberg S; Merkestein M; Hogendorf WFJ; Lund ML; Buijink JA; Damgaard J; Lykkesfeldt J; Holst B
FASEB J; 2023 Jun; 37(6):e22923. PubMed ID: 37104087
[TBL] [Abstract][Full Text] [Related]
19. LEAP2 Impairs the Capability of the Growth Hormone Secretagogue Receptor to Regulate the Dopamine 2 Receptor Signaling.
Mustafá ER; Cordisco González S; Damian M; Cantel S; Denoyelle S; Wagner R; Schiöth HB; Fehrentz JA; Banères JL; Perelló M; Raingo J
Front Pharmacol; 2021; 12():712437. PubMed ID: 34447311
[TBL] [Abstract][Full Text] [Related]
20. Elevation of growth hormone secretagogue receptor type 1a mRNA expression in human growth hormone-secreting pituitary adenoma harboring G protein alpha subunit mutation.
Xu T; Ye F; Wang B; Tian C; Wang S; Shu K; Guo D; Lei T
Neuro Endocrinol Lett; 2010; 31(1):147-54. PubMed ID: 20150876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
